Leprosy (Hansen's Disease)

Current Treatment Options in Neurology

Volumn 6, Issue 2, 2004, Pages 95-103

  Bartt, Russell E ^a  

^a Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CLOFAZIMINE; CORTICOSTEROID DERIVATIVE; DAPSONE; ISONIAZID; MINOCYCLINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; OPIATE DERIVATIVE; ORAL CONTRACEPTIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; THALIDOMIDE; WARFARIN;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATAXIA; BORDERLINE LEPROSY; BURNING SENSATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DIARRHEA; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG COST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; ENTERITIS; ENTEROPATHY; EOSINOPHILIA; EPIDEMIC; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HEMOLYSIS; HUMAN; IMMIGRANT; IMMUNE RESPONSE; IMMUNE STATUS; INSOMNIA; LEG EDEMA; LEPROMATOUS LEPROSY; LEPROSY; LIVER TOXICITY; LYMPHADENOPATHY; MOTOR NEUROPATHY; MYCOBACTERIUM LEPRAE; NAIL PIGMENTATION; NAUSEA; NERVE DECOMPRESSION; NEUROLOGIC DISEASE; PATHOGENESIS; PERIPHERAL NERVE; PHOTOSENSITIVITY DISORDER; PHYSICAL DISABILITY; PHYSIOTHERAPY; POLYNEUROPATHY; PRURITUS; QT PROLONGATION; REVIEW; SEIZURE; SKIN DEFECT; SKIN DISCOLORATION; SKIN INFECTION; TENDON RUPTURE; TREATMENT OUTCOME; TUBERCULOID LEPROSY; UNITED STATES; UREMIA; VESTIBULAR DISORDER; VOMITING;

EID: 5444223024     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0019-2     Document Type: Review

References (33)

1. World Health Organization LEG: Elimination of leprosy as a public health problem. Available at www.who.int/lep/index.html.
2. Stearns AT: Leprosy: a problem solved by 2000? Lepr Rev 2002, 73: 215-224.
3. Ooi WW, Moschella SL: Update on leprosy in immigrants in the United States: status in the year 2000. Clin Infect Dis 2001, 32: 930-937.
4. Mastro TD, Redd SC, Breiman RF: Imported leprosy in the United States 1978 through 1988: an epidemic without secondary transmission. Am J Pub Health 1992, 82: 1127-1130.
5. Lerner S: Cases of leprosy on the rise in the US. Available at http://www.iht.com/articles/87291.html.
6. Willett H: Mycobacterium. In Zinsser Microbiology, edn 20. Edited by Joklik W, Willett H, Amos D, Wilfert C. Norwalk: Appleton and Lange; 1992:497-525.
7. Rea TH, Modlin RL: Leprosy. In Dermatology in General Medicine, edn 6. Edited by Freedberg IM, Eisen AZ, Wolff K, et al. New York: McGraw-Hill; 2003:1962-1971.
8. Izumi S: Subclinical infection by Mycobacterium leprae. Int J Lepr 1999, 67(suppl): S67-S71.
9. Sabin TD, Swift TR, Jacobson RR: Leprosy. In Peripheral Neuropathy, edn 3. Philadelphia: W.B. Saunders; 1993:1354-1379.
10. Ridley D, Jopling W: Classification of leprosy according to immunity: a five group system. Int J Lepr 1966, 34: 255-273.
11. Murray K, McLelland B, Job C: Early leprosy with perineural proliferation. Arch Derm 1984, 120: 360-361.
12. Bleharski JR, Huiying L, Meinkin C, et al.: Using genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003, 301: 1527-1530.
13. World Health Organization: WHO recommended MDT treatment guidelines. Available at http://www.who.int/lep/disease/disease.htm.
14. Jacobson RR, Krahenbuhl J: Leprosy. Lancet 1999, 353: 655-660.
15. Lyde CB: Pregnancy in patients with Hansen's disease. Arch Derm 1997, 133: 623-627.
16. Lockwood D, Marlowe S: Leprosy. In Antibiotic and Chemotherapy, edn 8. Edited by Finch RG, Greenwood D, Norrby SR, Whitley RJ. Edinburgh: Churchill Livingstone; 2003:808-816.
17. Petri WAJ: Drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease and leprosy. In Goodman and Gilman's the Pharmacologic Basis of Therapeutics, edn 10. Edited by Hardman JG, Limbird LE, Gilman AG. New York: McGraw-Hill; 2001:1273-1294.
18. Waldinger TP, Siegle RJ, Weber W, et al.: Dapsone-induced peripheral neuropathy. Arch Derm 1984, 120: 356-359.
19. Koller WC, Gehlman LK, Malkinson FD, et al.: Dapsone-induced peripheral neuropathy. Arch Neurol 1977, 34: 644-646.
20. Navarro JC, Rosales RL, Ordinario AT, et al.: Acute dapsone-induced peripheral neuropathy. Muscle Nerve 1989, 12: 604-606.
21. Sirsat AM, Lalitha VS, Pandya SS: Dapsone neuropathy: report of three cases and pathologic features of a motor nerve. Int J Lepr 1987, 55: 23-29.
22. Grange J: Antimycobacterial agents. In Antibiotic and Chemotherapy. Edited by Finch RG, Greenwood D, Norrby SR, Whitley RJ. Edinburgh: Churchill Livingstone; 2003:427-440.
23. Sukpanichnant S, Hargrove NS, Kachintorn U, et al.: Clofazamine-induced crystal-storing histiocytosis producing chronic abdominal pain in leprosy patient. Am J Surg Path 2000, 24: 129-135.
24. Ji B, Jamet P, Bobin P, et al.: Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J Infect Dis 1993, 168: 188-190.
25. Chambers HF: Protein synthesis inhibitors and miscellaneous antibacterial agents. In Goodman and Gilman's The Pharmacologic Basis of Therapeutics. Edited by Hardman JG, Limbird LE, Gilman AG. New York: McGrawHill; 2001:1239-1271.
26. Chaudhry V, Cornblath D, Corse A, et al.: Thalidomide-induced neuropathy. Neurology 2002, 59: 1872-1875.
27. Krensky AM, Strom TB, Bluestone JA: Immunomodulators: immunosuppressive agents, tolerogens and immunostimulants. In Goodman and Gilman's The Pharmacologic Basis of Therapeutics. Edited by Hardman JG, Limbird LE, Gilman AG. New York: McGraw-Hill; 2001:1463-1484.
28. Kumar K: Surgical management of leprous ulnar neuritis. Clin Ortho 1982, 163: 235-242.
29. Amer M, Gawish H, Samed I, El Hawala A, et al.: Clinical electrophysiologic assessment of ulnar nerve transposition in tuberculoid leprosy. Int J Derm 1983, 22: 481-484.
30. Ebenezer M, Andrews P, Solomon S: Comparative trial of steroids and surgical intervention in the treatment of ulnar neuritis. Int J Lepr 1996, 64: 282-286.
31. Cross H, Kulkarni VN, Dey A, et al.: Planter ulceration in leprosy. J Wound Care 1996, 5: 406-411.
32. Chen XS, Li WZ, Jiang C, et al.: Leprosy in children: a retrospective study in China 1986-1997. J Trop Ped 2000, 46: 207-211.
33. Sehgal VN, Chaudhry AK: Leprosy in children: a prospective study. Int J Derm 1993, 32: 194-197.